MABWELL SHANGHAI BIOSCIENCE CO LTD has a total of 15 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2017. It filed its patents most often in China, WIPO (World Intellectual Property Organization) and Canada. Its main competitors in its focus markets pharmaceuticals, biotechnology and organic fine chemistry are ZAKL FARMACEUTYCZNE POLPHARMA SA, LUNAN NEW TIME BIO TECH CO LTD and ACUMEN PHARMACEUTICALS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 6 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Canada | 1 | |
#4 | EPO (European Patent Office) | 1 | |
#5 | Republic of Korea | 1 | |
#6 | Taiwan | 1 | |
#7 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Organic fine chemistry | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Peptides | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Microorganisms | |
#5 | Heterocyclic compounds | |
#6 | Analysing materials | |
#7 | Fermentation |
# | Name | Total Patents |
---|---|---|
#1 | Chen Lin | 5 |
#2 | Wang Ying | 5 |
#3 | Shen Jingkang | 5 |
#4 | Peng Hongli | 5 |
#5 | Meng Tao | 5 |
#6 | Ma Lanping | 5 |
#7 | Wang Xin | 5 |
#8 | Yu Ting | 5 |
#9 | Du Zhiyan | 5 |
#10 | Zhang Yongliang | 5 |
Publication | Filing date | Title |
---|---|---|
WO2021068949A1 | Anti-human trop-2 antibody and application thereof | |
WO2021058000A1 | Anti-human claudin 18.2 antibody and application thereof | |
WO2021052461A1 | Anti-alpha-hemolysin antibody and use thereof | |
CN111808201A | Preparation method of recombinant human glucagon-like peptide-1 analogue fusion protein | |
CN111704670A | Disulfide bond isomer of recombinant anti-RANKL antibody IgG2 type and purification method thereof | |
CN110045131A | Method for measuring the biological activity of people's IL-33/ST2 pathway inhibitor | |
CN109369806A | The minimizing technology of cysteine variant in Su Jin monoclonal antibody product | |
CN111423510A | Recombinant anti-human PD-1 antibody and application thereof | |
US2019388555A1 | Di-substituted maleic amide linker for antibody drug conjugating and preparation method and use thereof |